ViiV trials long-acting, two-drug HIV regimen
admin 28th November 2017 Uncategorised 0ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults with HIV-1 infection
More: ViiV trials long-acting, two-drug HIV regimen
Source: News